4Front Ventures Corp.
4Front Ventures Corp. (FFNTF) Stock Competitors & Peer Comparison
See (FFNTF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| FFNTF | $0.00 | -80.00% | 12.5K | N/A | -$0.11 | N/A |
| IPSEY | $47.95 | -0.12% | 63.4B | 30.74 | $1.56 | +0.83% |
| MKKGY | $26.00 | -1.25% | 56.5B | 18.57 | $1.40 | +1.93% |
| TKPHF | $35.00 | +1.39% | 55.3B | 79.55 | $0.44 | +3.72% |
| MKGAF | $130.71 | -0.96% | 55B | 18.01 | $7.02 | +1.50% |
| HLNCF | $4.78 | -3.43% | 42.6B | 19.12 | $0.25 | +2.05% |
| SDZNY | $79.83 | -1.40% | 34.7B | 38.35 | $2.09 | +0.77% |
| TEVJF | $29.19 | +2.93% | 34B | 24.12 | $1.21 | N/A |
| SGIOF | $22.63 | +18.48% | 19.3B | 17.96 | $1.26 | +1.97% |
| TAIPY | $14.00 | +16.67% | 18.1B | 82.35 | $0.17 | N/A |
Stock Comparison
FFNTF vs IPSEY Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, IPSEY has a market cap of 63.4B. Regarding current trading prices, FFNTF is priced at $0.00, while IPSEY trades at $47.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas IPSEY's P/E ratio is 30.74. In terms of profitability, FFNTF's ROE is +7.89%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, FFNTF is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check IPSEY's competition here
FFNTF vs MKKGY Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, MKKGY has a market cap of 56.5B. Regarding current trading prices, FFNTF is priced at $0.00, while MKKGY trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas MKKGY's P/E ratio is 18.57. In terms of profitability, FFNTF's ROE is +7.89%, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, FFNTF is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check MKKGY's competition here
FFNTF vs TKPHF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, TKPHF has a market cap of 55.3B. Regarding current trading prices, FFNTF is priced at $0.00, while TKPHF trades at $35.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas TKPHF's P/E ratio is 79.55. In terms of profitability, FFNTF's ROE is +7.89%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, FFNTF is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check TKPHF's competition here
FFNTF vs MKGAF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, MKGAF has a market cap of 55B. Regarding current trading prices, FFNTF is priced at $0.00, while MKGAF trades at $130.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas MKGAF's P/E ratio is 18.01. In terms of profitability, FFNTF's ROE is +7.89%, compared to MKGAF's ROE of +0.09%. Regarding short-term risk, FFNTF is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check MKGAF's competition here
FFNTF vs HLNCF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, HLNCF has a market cap of 42.6B. Regarding current trading prices, FFNTF is priced at $0.00, while HLNCF trades at $4.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas HLNCF's P/E ratio is 19.12. In terms of profitability, FFNTF's ROE is +7.89%, compared to HLNCF's ROE of +0.06%. Regarding short-term risk, FFNTF is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check HLNCF's competition here
FFNTF vs SDZNY Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, SDZNY has a market cap of 34.7B. Regarding current trading prices, FFNTF is priced at $0.00, while SDZNY trades at $79.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas SDZNY's P/E ratio is 38.35. In terms of profitability, FFNTF's ROE is +7.89%, compared to SDZNY's ROE of +0.08%. Regarding short-term risk, FFNTF is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check SDZNY's competition here
FFNTF vs TEVJF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, TEVJF has a market cap of 34B. Regarding current trading prices, FFNTF is priced at $0.00, while TEVJF trades at $29.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas TEVJF's P/E ratio is 24.12. In terms of profitability, FFNTF's ROE is +7.89%, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, FFNTF is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check TEVJF's competition here
FFNTF vs SGIOF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, SGIOF has a market cap of 19.3B. Regarding current trading prices, FFNTF is priced at $0.00, while SGIOF trades at $22.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas SGIOF's P/E ratio is 17.96. In terms of profitability, FFNTF's ROE is +7.89%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, FFNTF is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check SGIOF's competition here
FFNTF vs TAIPY Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, FFNTF is priced at $0.00, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, FFNTF's ROE is +7.89%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, FFNTF is more volatile compared to TAIPY. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check TAIPY's competition here
FFNTF vs ESALY Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, FFNTF is priced at $0.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas ESALY's P/E ratio is 20.54. In terms of profitability, FFNTF's ROE is +7.89%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, FFNTF is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check ESALY's competition here
FFNTF vs SGIOY Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, SGIOY has a market cap of 16.5B. Regarding current trading prices, FFNTF is priced at $0.00, while SGIOY trades at $9.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas SGIOY's P/E ratio is 15.39. In terms of profitability, FFNTF's ROE is +7.89%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, FFNTF is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check SGIOY's competition here
FFNTF vs BIOVF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, BIOVF has a market cap of 14.9B. Regarding current trading prices, FFNTF is priced at $0.00, while BIOVF trades at $43.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas BIOVF's P/E ratio is 287.67. In terms of profitability, FFNTF's ROE is +7.89%, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, FFNTF is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check BIOVF's competition here
FFNTF vs IPSEF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, IPSEF has a market cap of 9.7B. Regarding current trading prices, FFNTF is priced at $0.00, while IPSEF trades at $117.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas IPSEF's P/E ratio is 18.79. In terms of profitability, FFNTF's ROE is +7.89%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, FFNTF is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check IPSEF's competition here
FFNTF vs ESALF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, ESALF has a market cap of 9.3B. Regarding current trading prices, FFNTF is priced at $0.00, while ESALF trades at $33.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas ESALF's P/E ratio is 30.00. In terms of profitability, FFNTF's ROE is +7.89%, compared to ESALF's ROE of +0.05%. Regarding short-term risk, FFNTF is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check ESALF's competition here
FFNTF vs ESAIY Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, ESAIY has a market cap of 8B. Regarding current trading prices, FFNTF is priced at $0.00, while ESAIY trades at $7.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas ESAIY's P/E ratio is 26.33. In terms of profitability, FFNTF's ROE is +7.89%, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, FFNTF is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check ESAIY's competition here
FFNTF vs SFOSF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, SFOSF has a market cap of 6.9B. Regarding current trading prices, FFNTF is priced at $0.00, while SFOSF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas SFOSF's P/E ratio is 13.68. In terms of profitability, FFNTF's ROE is +7.89%, compared to SFOSF's ROE of +0.09%. Regarding short-term risk, FFNTF is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check SFOSF's competition here
FFNTF vs GZPHF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, GZPHF has a market cap of 6.2B. Regarding current trading prices, FFNTF is priced at $0.00, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, FFNTF's ROE is +7.89%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, FFNTF is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check GZPHF's competition here
FFNTF vs DNPUF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, DNPUF has a market cap of 5.9B. Regarding current trading prices, FFNTF is priced at $0.00, while DNPUF trades at $14.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas DNPUF's P/E ratio is 6.04. In terms of profitability, FFNTF's ROE is +7.89%, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, FFNTF is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check DNPUF's competition here
FFNTF vs HLBBF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, HLBBF has a market cap of 5.5B. Regarding current trading prices, FFNTF is priced at $0.00, while HLBBF trades at $6.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas HLBBF's P/E ratio is 13.53. In terms of profitability, FFNTF's ROE is +7.89%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, FFNTF is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check HLBBF's competition here
FFNTF vs HLUBF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, HLUBF has a market cap of 5.3B. Regarding current trading prices, FFNTF is priced at $0.00, while HLUBF trades at $5.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas HLUBF's P/E ratio is 10.74. In terms of profitability, FFNTF's ROE is +7.89%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, FFNTF is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check HLUBF's competition here
FFNTF vs LVZPF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, LVZPF has a market cap of 5.1B. Regarding current trading prices, FFNTF is priced at $0.00, while LVZPF trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas LVZPF's P/E ratio is 12.79. In terms of profitability, FFNTF's ROE is +7.89%, compared to LVZPF's ROE of +0.14%. Regarding short-term risk, FFNTF is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check LVZPF's competition here
FFNTF vs SMDPY Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, SMDPY has a market cap of 4.5B. Regarding current trading prices, FFNTF is priced at $0.00, while SMDPY trades at $11.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas SMDPY's P/E ratio is 4.59. In terms of profitability, FFNTF's ROE is +7.89%, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, FFNTF is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check SMDPY's competition here
FFNTF vs SGFEF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, FFNTF is priced at $0.00, while SGFEF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas SGFEF's P/E ratio is 20.28. In terms of profitability, FFNTF's ROE is +7.89%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, FFNTF is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for FFNTF.Check SGFEF's competition here
FFNTF vs HKMPY Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, HKMPY has a market cap of 4.1B. Regarding current trading prices, FFNTF is priced at $0.00, while HKMPY trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas HKMPY's P/E ratio is 10.36. In terms of profitability, FFNTF's ROE is +7.89%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, FFNTF is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check HKMPY's competition here
FFNTF vs HKMPF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, HKMPF has a market cap of 3.9B. Regarding current trading prices, FFNTF is priced at $0.00, while HKMPF trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas HKMPF's P/E ratio is 9.94. In terms of profitability, FFNTF's ROE is +7.89%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, FFNTF is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check HKMPF's competition here
FFNTF vs APNHY Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, APNHY has a market cap of 3.8B. Regarding current trading prices, FFNTF is priced at $0.00, while APNHY trades at $8.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas APNHY's P/E ratio is -34.52. In terms of profitability, FFNTF's ROE is +7.89%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, FFNTF is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check APNHY's competition here
FFNTF vs APNHF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, FFNTF is priced at $0.00, while APNHF trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas APNHF's P/E ratio is -32.80. In terms of profitability, FFNTF's ROE is +7.89%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, FFNTF is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check APNHF's competition here
FFNTF vs LBTSF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, FFNTF is priced at $0.00, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas LBTSF's P/E ratio is 59.04. In terms of profitability, FFNTF's ROE is +7.89%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, FFNTF is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check LBTSF's competition here
FFNTF vs HYPMY Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, HYPMY has a market cap of 3.2B. Regarding current trading prices, FFNTF is priced at $0.00, while HYPMY trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas HYPMY's P/E ratio is 12.43. In terms of profitability, FFNTF's ROE is +7.89%, compared to HYPMY's ROE of +0.10%. Regarding short-term risk, FFNTF is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check HYPMY's competition here
FFNTF vs INVVY Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, FFNTF is priced at $0.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas INVVY's P/E ratio is -62.42. In terms of profitability, FFNTF's ROE is +7.89%, compared to INVVY's ROE of -0.99%. Regarding short-term risk, FFNTF is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check INVVY's competition here
FFNTF vs IZQVF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, FFNTF is priced at $0.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, FFNTF's ROE is +7.89%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, FFNTF is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check IZQVF's competition here
FFNTF vs CURLF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, CURLF has a market cap of 2.6B. Regarding current trading prices, FFNTF is priced at $0.00, while CURLF trades at $3.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas CURLF's P/E ratio is -10.57. In terms of profitability, FFNTF's ROE is +7.89%, compared to CURLF's ROE of -0.29%. Regarding short-term risk, FFNTF is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check CURLF's competition here
FFNTF vs DMPHF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, DMPHF has a market cap of 2.6B. Regarding current trading prices, FFNTF is priced at $0.00, while DMPHF trades at $48.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas DMPHF's P/E ratio is 21.99. In terms of profitability, FFNTF's ROE is +7.89%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, FFNTF is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check DMPHF's competition here
FFNTF vs ULIHF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, ULIHF has a market cap of 2.6B. Regarding current trading prices, FFNTF is priced at $0.00, while ULIHF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas ULIHF's P/E ratio is 8.13. In terms of profitability, FFNTF's ROE is +7.89%, compared to ULIHF's ROE of +0.13%. Regarding short-term risk, FFNTF is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check ULIHF's competition here
FFNTF vs HMDCF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, HMDCF has a market cap of 2.5B. Regarding current trading prices, FFNTF is priced at $0.00, while HMDCF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas HMDCF's P/E ratio is 5.47. In terms of profitability, FFNTF's ROE is +7.89%, compared to HMDCF's ROE of +0.41%. Regarding short-term risk, FFNTF is more volatile compared to HMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check HMDCF's competition here
FFNTF vs NPPNY Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, NPPNY has a market cap of 2.3B. Regarding current trading prices, FFNTF is priced at $0.00, while NPPNY trades at $8.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas NPPNY's P/E ratio is 11.77. In terms of profitability, FFNTF's ROE is +7.89%, compared to NPPNY's ROE of +0.12%. Regarding short-term risk, FFNTF is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check NPPNY's competition here
FFNTF vs CHSYF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, CHSYF has a market cap of 2.3B. Regarding current trading prices, FFNTF is priced at $0.00, while CHSYF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas CHSYF's P/E ratio is 9.31. In terms of profitability, FFNTF's ROE is +7.89%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, FFNTF is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check CHSYF's competition here
FFNTF vs NPNKF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, NPNKF has a market cap of 2.2B. Regarding current trading prices, FFNTF is priced at $0.00, while NPNKF trades at $32.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas NPNKF's P/E ratio is 11.03. In terms of profitability, FFNTF's ROE is +7.89%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, FFNTF is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check NPNKF's competition here
FFNTF vs TSMRF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, TSMRF has a market cap of 2.1B. Regarding current trading prices, FFNTF is priced at $0.00, while TSMRF trades at $28.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas TSMRF's P/E ratio is 12.19. In terms of profitability, FFNTF's ROE is +7.89%, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, FFNTF is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check TSMRF's competition here
FFNTF vs HTSUF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, FFNTF is priced at $0.00, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, FFNTF's ROE is +7.89%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, FFNTF is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check HTSUF's competition here
FFNTF vs ARSUF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, ARSUF has a market cap of 2B. Regarding current trading prices, FFNTF is priced at $0.00, while ARSUF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas ARSUF's P/E ratio is 18.49. In terms of profitability, FFNTF's ROE is +7.89%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, FFNTF is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check ARSUF's competition here
FFNTF vs DUTV Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, FFNTF is priced at $0.00, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas DUTV's P/E ratio is N/A. In terms of profitability, FFNTF's ROE is +7.89%, compared to DUTV's ROE of -0.04%. Regarding short-term risk, FFNTF is more volatile compared to DUTV. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check DUTV's competition here
FFNTF vs GTBIF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, GTBIF has a market cap of 1.9B. Regarding current trading prices, FFNTF is priced at $0.00, while GTBIF trades at $8.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas GTBIF's P/E ratio is 16.68. In terms of profitability, FFNTF's ROE is +7.89%, compared to GTBIF's ROE of +0.06%. Regarding short-term risk, FFNTF is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check GTBIF's competition here
FFNTF vs TCNNF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, TCNNF has a market cap of 1.8B. Regarding current trading prices, FFNTF is priced at $0.00, while TCNNF trades at $9.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas TCNNF's P/E ratio is -16.10. In terms of profitability, FFNTF's ROE is +7.89%, compared to TCNNF's ROE of -0.10%. Regarding short-term risk, FFNTF is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check TCNNF's competition here
FFNTF vs SHPHF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, FFNTF is priced at $0.00, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, FFNTF's ROE is +7.89%, compared to SHPHF's ROE of +0.03%. Regarding short-term risk, FFNTF is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check SHPHF's competition here
FFNTF vs MITPF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, FFNTF is priced at $0.00, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas MITPF's P/E ratio is -10.81. In terms of profitability, FFNTF's ROE is +7.89%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, FFNTF is more volatile compared to MITPF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check MITPF's competition here
FFNTF vs KARBF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, FFNTF is priced at $0.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas KARBF's P/E ratio is 262.50. In terms of profitability, FFNTF's ROE is +7.89%, compared to KARBF's ROE of N/A. Regarding short-term risk, FFNTF is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check KARBF's competition here
FFNTF vs CASBF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, CASBF has a market cap of 1.4B. Regarding current trading prices, FFNTF is priced at $0.00, while CASBF trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas CASBF's P/E ratio is -39.70. In terms of profitability, FFNTF's ROE is +7.89%, compared to CASBF's ROE of +0.01%. Regarding short-term risk, FFNTF is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check CASBF's competition here
FFNTF vs CHIZF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, FFNTF is priced at $0.00, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, FFNTF's ROE is +7.89%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, FFNTF is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check CHIZF's competition here
FFNTF vs SWGHF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, FFNTF is priced at $0.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, FFNTF's ROE is +7.89%, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, FFNTF is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check SWGHF's competition here
FFNTF vs KSPHF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, KSPHF has a market cap of 1.3B. Regarding current trading prices, FFNTF is priced at $0.00, while KSPHF trades at $30.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas KSPHF's P/E ratio is 14.08. In terms of profitability, FFNTF's ROE is +7.89%, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, FFNTF is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check KSPHF's competition here
FFNTF vs EVOTF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, EVOTF has a market cap of 1.3B. Regarding current trading prices, FFNTF is priced at $0.00, while EVOTF trades at $7.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas EVOTF's P/E ratio is -10.37. In terms of profitability, FFNTF's ROE is +7.89%, compared to EVOTF's ROE of -0.12%. Regarding short-term risk, FFNTF is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check EVOTF's competition here
FFNTF vs TWAPF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, TWAPF has a market cap of 1.2B. Regarding current trading prices, FFNTF is priced at $0.00, while TWAPF trades at $25.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas TWAPF's P/E ratio is 9.45. In terms of profitability, FFNTF's ROE is +7.89%, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, FFNTF is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check TWAPF's competition here
FFNTF vs LJUIF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, FFNTF is priced at $0.00, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, FFNTF's ROE is +7.89%, compared to LJUIF's ROE of +0.06%. Regarding short-term risk, FFNTF is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check LJUIF's competition here
FFNTF vs BIOGY Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, FFNTF is priced at $0.00, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, FFNTF's ROE is +7.89%, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, FFNTF is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check BIOGY's competition here
FFNTF vs SHEZF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, SHEZF has a market cap of 1.1B. Regarding current trading prices, FFNTF is priced at $0.00, while SHEZF trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas SHEZF's P/E ratio is -36.03. In terms of profitability, FFNTF's ROE is +7.89%, compared to SHEZF's ROE of +0.01%. Regarding short-term risk, FFNTF is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check SHEZF's competition here
FFNTF vs KKPCF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, KKPCF has a market cap of 1B. Regarding current trading prices, FFNTF is priced at $0.00, while KKPCF trades at $26.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas KKPCF's P/E ratio is 297.56. In terms of profitability, FFNTF's ROE is +7.89%, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, FFNTF is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check KKPCF's competition here
FFNTF vs GNMLF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, GNMLF has a market cap of 925.1M. Regarding current trading prices, FFNTF is priced at $0.00, while GNMLF trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas GNMLF's P/E ratio is 9.50. In terms of profitability, FFNTF's ROE is +7.89%, compared to GNMLF's ROE of +0.08%. Regarding short-term risk, FFNTF is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check GNMLF's competition here
FFNTF vs CSWYF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, CSWYF has a market cap of 815.8M. Regarding current trading prices, FFNTF is priced at $0.00, while CSWYF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas CSWYF's P/E ratio is 5.14. In terms of profitability, FFNTF's ROE is +7.89%, compared to CSWYF's ROE of +0.12%. Regarding short-term risk, FFNTF is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check CSWYF's competition here
FFNTF vs GLASF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, GLASF has a market cap of 789.4M. Regarding current trading prices, FFNTF is priced at $0.00, while GLASF trades at $10.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas GLASF's P/E ratio is -18.54. In terms of profitability, FFNTF's ROE is +7.89%, compared to GLASF's ROE of -0.23%. Regarding short-term risk, FFNTF is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check GLASF's competition here
FFNTF vs TRXPF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, FFNTF is priced at $0.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, FFNTF's ROE is +7.89%, compared to TRXPF's ROE of +0.03%. Regarding short-term risk, FFNTF is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check TRXPF's competition here
FFNTF vs YIHCF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, FFNTF is priced at $0.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, FFNTF's ROE is +7.89%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, FFNTF is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check YIHCF's competition here
FFNTF vs AIHLF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, FFNTF is priced at $0.00, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, FFNTF's ROE is +7.89%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, FFNTF is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check AIHLF's competition here
FFNTF vs TRSSF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, FFNTF is priced at $0.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, FFNTF's ROE is +7.89%, compared to TRSSF's ROE of -0.68%. Regarding short-term risk, FFNTF is more volatile compared to TRSSF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check TRSSF's competition here
FFNTF vs SWDCF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, SWDCF has a market cap of 575.4M. Regarding current trading prices, FFNTF is priced at $0.00, while SWDCF trades at $3.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas SWDCF's P/E ratio is 120.00. In terms of profitability, FFNTF's ROE is +7.89%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, FFNTF is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check SWDCF's competition here
FFNTF vs AGYTF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, AGYTF has a market cap of 554.6M. Regarding current trading prices, FFNTF is priced at $0.00, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, FFNTF's ROE is +7.89%, compared to AGYTF's ROE of +2.84%. Regarding short-term risk, FFNTF is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check AGYTF's competition here
FFNTF vs PKBFF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, FFNTF is priced at $0.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas PKBFF's P/E ratio is N/A. In terms of profitability, FFNTF's ROE is +7.89%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, FFNTF is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check PKBFF's competition here
FFNTF vs KHTRF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, KHTRF has a market cap of 544.1M. Regarding current trading prices, FFNTF is priced at $0.00, while KHTRF trades at $5.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas KHTRF's P/E ratio is -138.75. In terms of profitability, FFNTF's ROE is +7.89%, compared to KHTRF's ROE of -0.01%. Regarding short-term risk, FFNTF is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check KHTRF's competition here
FFNTF vs CCHWF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, FFNTF is priced at $0.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, FFNTF's ROE is +7.89%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, FFNTF is more volatile compared to CCHWF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check CCHWF's competition here
FFNTF vs BOIRF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, FFNTF is priced at $0.00, while BOIRF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, FFNTF's ROE is +7.89%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, FFNTF is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check BOIRF's competition here
FFNTF vs VRNOF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, VRNOF has a market cap of 470.4M. Regarding current trading prices, FFNTF is priced at $0.00, while VRNOF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas VRNOF's P/E ratio is -1.31. In terms of profitability, FFNTF's ROE is +7.89%, compared to VRNOF's ROE of -0.30%. Regarding short-term risk, FFNTF is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check VRNOF's competition here
FFNTF vs PEXXF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, FFNTF is priced at $0.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, FFNTF's ROE is +7.89%, compared to PEXXF's ROE of N/A. Regarding short-term risk, FFNTF is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check PEXXF's competition here
FFNTF vs HUMDF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, HUMDF has a market cap of 405.4M. Regarding current trading prices, FFNTF is priced at $0.00, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas HUMDF's P/E ratio is 2.57. In terms of profitability, FFNTF's ROE is +7.89%, compared to HUMDF's ROE of +1.07%. Regarding short-term risk, FFNTF is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check HUMDF's competition here
FFNTF vs ELTP Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, ELTP has a market cap of 375.5M. Regarding current trading prices, FFNTF is priced at $0.00, while ELTP trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas ELTP's P/E ratio is 8.72. In terms of profitability, FFNTF's ROE is +7.89%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, FFNTF is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check ELTP's competition here
FFNTF vs CRLBF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, CRLBF has a market cap of 374.1M. Regarding current trading prices, FFNTF is priced at $0.00, while CRLBF trades at $1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas CRLBF's P/E ratio is -2.87. In terms of profitability, FFNTF's ROE is +7.89%, compared to CRLBF's ROE of -0.33%. Regarding short-term risk, FFNTF is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check CRLBF's competition here
FFNTF vs CPHRF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, CPHRF has a market cap of 341.3M. Regarding current trading prices, FFNTF is priced at $0.00, while CPHRF trades at $13.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas CPHRF's P/E ratio is 12.86. In terms of profitability, FFNTF's ROE is +7.89%, compared to CPHRF's ROE of +0.24%. Regarding short-term risk, FFNTF is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check CPHRF's competition here
FFNTF vs NIKA Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, NIKA has a market cap of 316.4M. Regarding current trading prices, FFNTF is priced at $0.00, while NIKA trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas NIKA's P/E ratio is N/A. In terms of profitability, FFNTF's ROE is +7.89%, compared to NIKA's ROE of +0.29%. Regarding short-term risk, FFNTF is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check NIKA's competition here
FFNTF vs BHCCF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, FFNTF is priced at $0.00, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, FFNTF's ROE is +7.89%, compared to BHCCF's ROE of +0.29%. Regarding short-term risk, FFNTF is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check BHCCF's competition here
FFNTF vs PLNHF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, FFNTF is priced at $0.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, FFNTF's ROE is +7.89%, compared to PLNHF's ROE of +659479.06%. Regarding short-term risk, FFNTF is more volatile compared to PLNHF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check PLNHF's competition here
FFNTF vs PHCUF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, PHCUF has a market cap of 186.2M. Regarding current trading prices, FFNTF is priced at $0.00, while PHCUF trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas PHCUF's P/E ratio is -700.00. In terms of profitability, FFNTF's ROE is +7.89%, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, FFNTF is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check PHCUF's competition here
FFNTF vs SHIEF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, SHIEF has a market cap of 179.4M. Regarding current trading prices, FFNTF is priced at $0.00, while SHIEF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas SHIEF's P/E ratio is -8.39. In terms of profitability, FFNTF's ROE is +7.89%, compared to SHIEF's ROE of +1.01%. Regarding short-term risk, FFNTF is more volatile compared to SHIEF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check SHIEF's competition here
FFNTF vs CBWTF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, CBWTF has a market cap of 144.1M. Regarding current trading prices, FFNTF is priced at $0.00, while CBWTF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas CBWTF's P/E ratio is 5.14. In terms of profitability, FFNTF's ROE is +7.89%, compared to CBWTF's ROE of +0.23%. Regarding short-term risk, FFNTF is more volatile compared to CBWTF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check CBWTF's competition here
FFNTF vs COPHF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, FFNTF is priced at $0.00, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas COPHF's P/E ratio is -0.02. In terms of profitability, FFNTF's ROE is +7.89%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, FFNTF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for FFNTF.Check COPHF's competition here
FFNTF vs LOVFF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, LOVFF has a market cap of 128.4M. Regarding current trading prices, FFNTF is priced at $0.00, while LOVFF trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas LOVFF's P/E ratio is 16.25. In terms of profitability, FFNTF's ROE is +7.89%, compared to LOVFF's ROE of +0.09%. Regarding short-term risk, FFNTF is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check LOVFF's competition here
FFNTF vs BIOYF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, BIOYF has a market cap of 125.1M. Regarding current trading prices, FFNTF is priced at $0.00, while BIOYF trades at $10.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas BIOYF's P/E ratio is 19.09. In terms of profitability, FFNTF's ROE is +7.89%, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, FFNTF is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check BIOYF's competition here
FFNTF vs NWPN Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, FFNTF is priced at $0.00, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas NWPN's P/E ratio is -0.04. In terms of profitability, FFNTF's ROE is +7.89%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, FFNTF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for FFNTF.Check NWPN's competition here
FFNTF vs AAWH Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, AAWH has a market cap of 111.2M. Regarding current trading prices, FFNTF is priced at $0.00, while AAWH trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas AAWH's P/E ratio is -0.93. In terms of profitability, FFNTF's ROE is +7.89%, compared to AAWH's ROE of -14.10%. Regarding short-term risk, FFNTF is more volatile compared to AAWH. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check AAWH's competition here
FFNTF vs LPCUF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, FFNTF is priced at $0.00, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas LPCUF's P/E ratio is 9.41. In terms of profitability, FFNTF's ROE is +7.89%, compared to LPCUF's ROE of +0.06%. Regarding short-term risk, FFNTF is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check LPCUF's competition here
FFNTF vs CNVCF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, FFNTF is priced at $0.00, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, FFNTF's ROE is +7.89%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, FFNTF is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check CNVCF's competition here
FFNTF vs CWBHF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, CWBHF has a market cap of 104.3M. Regarding current trading prices, FFNTF is priced at $0.00, while CWBHF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas CWBHF's P/E ratio is -3.42. In terms of profitability, FFNTF's ROE is +7.89%, compared to CWBHF's ROE of -2.75%. Regarding short-term risk, FFNTF is more volatile compared to CWBHF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check CWBHF's competition here
FFNTF vs JUSHF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, JUSHF has a market cap of 104.3M. Regarding current trading prices, FFNTF is priced at $0.00, while JUSHF trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas JUSHF's P/E ratio is -1.49. In terms of profitability, FFNTF's ROE is +7.89%, compared to JUSHF's ROE of +0.76%. Regarding short-term risk, FFNTF is more volatile compared to JUSHF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check JUSHF's competition here
FFNTF vs HLTRF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, HLTRF has a market cap of 103.2M. Regarding current trading prices, FFNTF is priced at $0.00, while HLTRF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas HLTRF's P/E ratio is -8.46. In terms of profitability, FFNTF's ROE is +7.89%, compared to HLTRF's ROE of -0.19%. Regarding short-term risk, FFNTF is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check HLTRF's competition here
FFNTF vs ORXOF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, ORXOF has a market cap of 101.9M. Regarding current trading prices, FFNTF is priced at $0.00, while ORXOF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas ORXOF's P/E ratio is -2.30. In terms of profitability, FFNTF's ROE is +7.89%, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, FFNTF is more volatile compared to ORXOF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check ORXOF's competition here
FFNTF vs ORXOY Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, ORXOY has a market cap of 98.4M. Regarding current trading prices, FFNTF is priced at $0.00, while ORXOY trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas ORXOY's P/E ratio is -2.24. In terms of profitability, FFNTF's ROE is +7.89%, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, FFNTF is more volatile compared to ORXOY. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check ORXOY's competition here
FFNTF vs MEDXF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, MEDXF has a market cap of 95.9M. Regarding current trading prices, FFNTF is priced at $0.00, while MEDXF trades at $2.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas MEDXF's P/E ratio is -148.50. In terms of profitability, FFNTF's ROE is +7.89%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, FFNTF is more volatile compared to MEDXF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check MEDXF's competition here
FFNTF vs GRUSF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, GRUSF has a market cap of 91.2M. Regarding current trading prices, FFNTF is priced at $0.00, while GRUSF trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas GRUSF's P/E ratio is 36.50. In terms of profitability, FFNTF's ROE is +7.89%, compared to GRUSF's ROE of +0.00%. Regarding short-term risk, FFNTF is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check GRUSF's competition here
FFNTF vs ABSCF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, ABSCF has a market cap of 90.7M. Regarding current trading prices, FFNTF is priced at $0.00, while ABSCF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas ABSCF's P/E ratio is -7.61. In terms of profitability, FFNTF's ROE is +7.89%, compared to ABSCF's ROE of +0.33%. Regarding short-term risk, FFNTF is more volatile compared to ABSCF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check ABSCF's competition here
FFNTF vs EOFBY Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, FFNTF is priced at $0.00, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, FFNTF's ROE is +7.89%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, FFNTF is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check EOFBY's competition here
FFNTF vs GDNSF Comparison April 2026
FFNTF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FFNTF stands at 12.5K. In comparison, GDNSF has a market cap of 61M. Regarding current trading prices, FFNTF is priced at $0.00, while GDNSF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FFNTF currently has a P/E ratio of N/A, whereas GDNSF's P/E ratio is -2.66. In terms of profitability, FFNTF's ROE is +7.89%, compared to GDNSF's ROE of -0.69%. Regarding short-term risk, FFNTF is more volatile compared to GDNSF. This indicates potentially higher risk in terms of short-term price fluctuations for FFNTF.Check GDNSF's competition here